The antisera market in France is forecasted to grow steadily from 2024 to 2028:
- 2024: $17.77 billion
- 2025: $18.275 billion
- 2026: $18.77 billion
- 2027: $19.255 billion
- 2028: $19.73 billion
As of 2023, the market stood at $17.3 billion, marking progressive growth annually.
Year-on-year growth rates from 2024 to 2028 show a consistent upward trend, indicating a stable increase in market value. The compound annual growth rate (CAGR) over this period highlights a solid, average annual growth.
Future trends to watch include advancements in biomedical research and increasing demand for antisera due to heightened focus on healthcare preparedness. Technological innovations may further drive market enhancements.
